AAAAAA
Results:
1-7
|
Results: 7
Authors:
Baltali, E
Ozisik, Y
Guler, N
Firat, D
Altundag, K
Citation: E. Baltali et al., Combination of docetaxel and doxorubicin as first-line chemotherapy in metastatic breast cancer, TUMORI, 87(1), 2001, pp. 18-19
Authors:
Barista, I
Baltali, E
Tekuzman, G
Kars, A
Ruacan, S
Ozisik, Y
Guler, N
Gullu, IH
Atahan, IL
Firat, D
Citation: I. Barista et al., Primary breast lymphomas - A retrospective analysis of twelve cases, ACTA ONCOL, 39(2), 2000, pp. 135-139
Authors:
Barista, I
Tekuzman, G
Yalcin, S
Gullu, I
Guler, N
Ozisik, Y
Kars, A
Celik, I
Turker, A
Altundag, K
Zengin, N
Uner, A
Baltali, E
Firat, D
Citation: I. Barista et al., Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicincombination chemotherapy, J SURG ONC, 73(1), 2000, pp. 12-16
Authors:
Ozyilkan, O
Baltali, E
Kirazli, S
Citation: O. Ozyilkan et al., CA 15-3, ceruloplasmin and tissue polypeptide specific antigen as a tumourmarker panel in breast cancer, E AFR MED J, 77(6), 2000, pp. 291-294
Authors:
Baltali, E
Gunel, N
Onat, DA
Atahan, IL
Akcali, Z
Buyukunal, E
Firat, D
Citation: E. Baltali et al., Neoadjuvant chemotherapy in locally advanced breast cancer: A preliminary report, TUMORI, 85(6), 1999, pp. 483-487
Authors:
Yalcin, S
Tekuzman, G
Baltali, E
Ozisik, Y
Barista, I
Citation: S. Yalcin et al., Serotonin receptor antagonists in prophylaxis of acute and delayed emesis induced by moderately emetogenic, single-day chemotherapy - A randomized study, AM J CL ONC, 22(1), 1999, pp. 94-96
Authors:
Celik, I
Altundag, K
Erman, M
Baltali, E
Citation: I. Celik et al., Cyclophosphamide-associated carcinoma of the urinary bladder in Behcet's disease, NEPHRON, 81(2), 1999, pp. 239-239
Risultati:
1-7
|